Biomarkers in Concussion

NCT05943561•Medstar Health Research Institute

Summary

This will be an observational study measuring serum Neurofilament Light Chain concentrations and associated symptoms, with a control branch, and a post-concussion branch.

Eligibility

Age

14 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Over 12 years of age Athletes participating on a sports team willing to participate; undergo blood draws either weekly or every two weeks, depending on arm of study.

Exclusion Criteria

•Existing active neurodegenerative disorder (ie severe TBI) Active peripheral nerve disorder (ie diabetic neuropathy)

Key Dates

Start Date

September 1, 2023

Primary Completion Date

June 1, 2024

Completion Date

June 1, 2024

Last Updated

September 5, 2023

Enrollment

100

ESTIMATED participants

Conditions

Concussion, MildConcussion, IntermediateConcussion, Severe

Contacts

Emma Merrill

CONTACT

2028776607 emma.merrill@medstar.net

Facilitating Access to Specialty Treatment

NCT05741411

Mild Traumatic Brain InjuryConcussion, Mild+2 more

View study

RECRUITINGPHASE2

BCAAs in Concussion 2.0

NCT06829498

Concussion, BrainConcussion, Mild+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 5, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

RECRUITINGPHASE2